PPS&V Asset Management Consultants’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,837
Closed -$293K 41
2026
Q1
$293K Buy
4,837
+89
+2% +$5.19K 0.18% 32
2025
Q4
$256K Sell
4,748
-455
-9% -$21.9K 0.15% 38
2025
Q3
$235K Sell
5,203
-701
-12% -$32.7K 0.14% 41
2025
Q2
$273K Buy
5,904
+177
+3% +$8.69K 0.17% 34
2025
Q1
$349K Sell
5,727
-97
-2% -$5.65K 0.25% 27
2024
Q4
$329K Buy
5,824
+307
+6% +$17.2K 0.22% 31
2024
Q3
$285K Buy
+5,517
New +$259K 0.2% 35

Other funds holding BMY

PPS&V Asset Management Consultants's BMY Position: Q2 2026 in Review

PPS&V Asset Management Consultants sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 4,837 shares — an estimated $293K sold.

PPS&V Asset Management Consultants first reported a position in BMY in Q3 2024 and held it in 7 quarters. The position peaked at $349K in Q1 2025. 721 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • PPS&V Asset Management Consultants reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • PPS&V Asset Management Consultants sold 4,837 Bristol-Myers Squibb shares in Q2 2026, an estimated $293K.
  • PPS&V Asset Management Consultants first reported a position in Bristol-Myers Squibb in Q3 2024 and held it in 7 quarters.
  • PPS&V Asset Management Consultants's Bristol-Myers Squibb position peaked at $349K in Q1 2025.
  • 721 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on PPS&V Asset Management Consultants's 13F filing for Q2 2026, filed 6 Jul 2026.